All Articles

Listen to Dr. Shanthi Sivendran, Senior Vice President of Cancer Care Support at the American Cancer Society and practicing medical oncologist, as she shines a spotlight on the ACS’s powerful, life-changing programs that support to patients and their families every step of the way.

This article will highlight common and serious adverse events (AEs) to be aware of when treating patients with antibody–drug conjugate therapy, as well as provide commentary from Tajuana Bradley, MS, FNP-BC, on key points of intervention when resolving these AEs and supporting patients through the treatment journey.

Hear from Dr. Greg Kalemkerian, a leading medical oncologist and professor at the University of Michigan, as he provides expert insights into the evolving landscape of lung cancer treatment.

Dr. Omid Hamid, Chief of Research and Immuno-Oncology at The Angeles Clinic and Research Institute, discusses advancements in immuno-oncology and shares his vision for the future of cancer care innovation.

This article explores the pharmacist’s vital role in mitigating adverse events, enhancing patient adherence, and optimizing therapeutic outcomes in patients being treated with antibody–drug conjugate therapies.